Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 25, 1991 - Issue sup138
Submit an article Journal homepage
0
Views
7
CrossRef citations to date
0
Altmetric
Carcinoma of the prostate

Evaluation of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Untreated Prostatic Carcinoma and Benign Prostatic Hyperplasia

J. F. A. T. BogdanowiczFrom the Department of Urology, University Hospital Dijkzigt, Rotterdam, the Netherlands, Department of Clinical Chemistry, Dr. Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
,
F. M. BentvelsenFrom the Department of Urology, University Hospital Dijkzigt, Rotterdam, the Netherlands, Department of Clinical Chemistry, Dr. Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
,
R. OosteromFrom the Department of Urology, University Hospital Dijkzigt, Rotterdam, the Netherlands, Department of Clinical Chemistry, Dr. Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
&
F. H. SchroederFrom the Department of Urology, University Hospital Dijkzigt, Rotterdam, the Netherlands, Department of Clinical Chemistry, Dr. Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
Pages 97-103 | Published online: 30 Mar 2023

REFERENCES

  • Ahmann, F.R., Schifman, R.B.: Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer. J Urol 1987; 137: 431–434.
  • Brawer, M.K., Rennels, M.A., Schifman, R.A., Nagle, R.B.: Significance of serum prostate specific antigen in men undergoing prostate surgery for benign disease. Am J Clin Pathol 1988; 89: 428.
  • Brawer, M.K., Lange, P.H.: PSA in the screening, staging and follow-up of early-stage prostate cancer. A review of recent developments. World J Urol 1989; 7: 7–11.
  • Chu, T.M., Murphy, G.P.: What's new in tumor markers for prostate cancer? Urology 1986; 27: 487–191.
  • Ferro, M.A., Barnes, I., Roberts, J.B.M., Smith, J.B.: Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. Br J Urol 1987; 60: 69–73.
  • Frankel, A.E., Rouse, R.V., Wang, M.C., Chu, T.M., Herzenberg, L.A.: Monoclonal antibodies to a human prostate antigen. Cancer Res 1982; 42: 3714–3718.
  • Graves, H.C.B., Wehner, N., Stamey, T.A.: Comparison of a polyclonal and monoclonal immunoassay for PSA: Need for an international antigen standard. J Urol 1990; 144: 1516–1522.
  • Kuriyama, M., Wang, M.C., Lee, C.L., Killian, C.S., Papsidero, L.D., Inaji, H., Loor, L.M., Lin, M.F., Nishiura, T., Slack, N.H., Murphy, G.P., Chu, T.M.: Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. JNCI 1982;
  • Liedtke, R.J., Batjer, J.D.: Measurement of prostatic specific antigen by radioimmunoassay. Clin Chem 1984; 30: 649–652.
  • Nadji, M. Tabei, S.Z., Castro A., Chu, T.M., Murphy, G.P., Wang, M.C., Morales, A.R.: Prostatic specific antigen: An immunohistologic marker for prostatic neoplasm. Cancer 1981; 48: 1229–1232.
  • Oosterom, R., Leijnse, B., Bogdanowicz, J., Schroeder, F.H.: Evaluation of an enzyme-immunoassay for prostatic acid phosphatase utilizing monoclonal antibodies. World J Urol 1986; 4: 153–158.
  • Oosterom, R., Bogdanowicz, J., Schroeder, F.H.: Evaluation of prostate specific antigen in untreated prostatic carcinoma. Eur Urol 1989; 16: 253–257.
  • Seamonds, B., Whitaker, B., Yang, N., Shaw L.M., Anderson, K., Bollinger J.R.: Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers. Urology 1986; 28: 472–479.
  • Shulman, S., Mamrod, L., Gonder, M.J., Soanes, W.A.: The detection of prostatic acid phosphatase by antibody reaction in gel diffusion. J Immunology 1964; 93: 474–480.
  • Siddall, J.K., Cooper, E.H., Newling, D.W.W., Robinson, M.R.G., Whelar, P.: An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate. Eur Urol 1986; 12: 123–130.
  • Stamey, T.A., Yang, N., Hay, A.R., McNeal, J.E., Freiha F.S., Redwine, E.: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–916.
  • Stamey, T.A., Kabalin, J.N., McNeal, J.E., Johnstone, I.M., Freiha, F., Redwine E.A., Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 1989; 141: 1076–1083.
  • Stamey, T.A., Kabalin, J.N., Ferrari, M.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. J Urol 1989; 141: 1084–1087.
  • Stamey, T.A., Kabalin, J.N., Ferrari, M., Yang, N.: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. J Urol 1989; 141: 1088–1090.
  • UICC (Union Internationale contre le Cancer). TNM Classification of Malignant Tumours. Third edition. Geneva: International Union against Cancer, 1978.
  • Wang, M.C., Valenzuela, L.A., Murphy G.P., Chu T.M.: Purification of a human prostate specific antigen. Invest Urol 1979; 17: 159–163.
  • Warholl, M.J., Longtime, J.A.: The ultrastructural localization of prostatic acid phosphatase in hyperplastic and neoplastic human prostates. J Urol 1985; 134: 607–613.
  • Watt, K.W.K., Lee, P.S., M'Timkulu, T., Chan, W.P., Loor, R.: Human prostate specific antigen: Structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986; 83: 3166–3170.
  • Weber, J.P., Oesterling, J.E., Peters, C.A., Partin, A.W., Chan, D.W., Walsh, P.C.: The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol 1989; 141: 987–992.
  • Yamabe, H., Ten Kate, F.J.W., Gallee, M.P.W., Schroeder, F.H., Oishi, K, Okada, K., Yoshida, O.: Stage A prostatic cancer: A comparative study in Japan and the Netherlands. World J Urol 1986; 4: 136–140. 68: 99–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.